Sunesis Pharmaceuticals to Host Conference Call on March 10th to Discuss Fourth Quarter and Full-Year 2019 Financial Results ...
March 03 2020 - 6:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that
it will host a conference call on Tuesday, March 10, 2020 at 4:30
p.m. Eastern Time to discuss corporate updates and financial
results for the fourth quarter and year ended December 31, 2019.
The call can be accessed by dialing (844)
296-7720 (U.S. and Canada) or (574) 990-1148 (International) and
entering passcode 2388763.
To access the live audio webcast, or the
subsequent archived recording, visit the "Investors and Media -
Calendar of Events" section of the Sunesis website at
http://ir.sunesis.com/events-and-presentations/upcoming-events. The
webcast will be recorded and available for replay on the company's
website for two weeks.
About Sunesis
Pharmaceuticals
Sunesis is a biopharmaceutical company
developing novel targeted inhibitors for the treatment of
hematologic and solid cancers. Sunesis has built an experienced
drug development organization committed to improving the lives of
people with cancer. The Company is focused on advancing its novel
kinase inhibitor pipeline, including its oral non-covalent BTK
inhibitor vecabrutinib and PDK1 inhibitor SNS-510. Vecabrutinib is
currently being evaluated in a Phase 1b/2 study in adults with
chronic lymphocytic leukemia and other B-cell malignancies that
have progressed after prior therapies.
For additional information on Sunesis, please
visit www.sunesis.com.
SUNESIS and the logos are trademarks of Sunesis
Pharmaceuticals, Inc.
Investor and Media Inquiries:Maeve ConneightonArgot
Partners212-600-1902 |
Willie QuinnSunesis Pharmaceuticals Inc.650-266-3716 |
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More News Articles